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Summary, general discussion and conclusions 





Chapter 1 introduces the concept of systemic inflammation after major 
surgery. The understanding of (systemic) inflammation in the context of surgery 
throughout previous centuries is described. Chapter 1 also describes the two patient 
groups studied: patients who had undergone orthotopic liver transplantation (OLT) on 
the one hand, and patients with ruptured abdominal aortic aneurysms (RAAA) on the 
other. The concept of the Systemic Inflammatory Response Syndrome (SIRS) is 
reviewed, and the role of monocyte function after OLT and RAAA is explored. 
In chapter 2 the pathogenesis of sepsis is described with a focus on the role of 
monocytes, immunomonitoring and treatment. In this review article, the two phase 
theory of sepsis is presented. The first phase represents the inflammatory response 
leading to the activation of monocytes with a systemic release of pro-inflammatory 
cytokines like TNF-, IL-1 and IL-6. The first phase is generally described as the 
Systemic Inflammatory Response Syndrome (SIRS). The second phase represents the 
anti-inflammatory phase with the release of anti-inflammatory cytokines as IL-10, and 
is referred to as the Compensatory Anti-inflammatory Response Syndrome (CARS). 
Despite enormous effort, most randomised controlled trials investigating a single drug-
intervention in sepsis did not show an improvement in survival. The intervention drugs 
used in these trials were almost always designed to counteract the inflammatory 
response, which is the first phase. The anti-inflammatory response may already have 
been in effect at the time the drugs were administered, which may account for the lack 
of successful intervention seen in these studies. In this chapter we elaborated on the 
role of HLA-DR expression on monocytes as a parameter for the inflammatory 
response. A normal or high HLA-DR expression on monocytes corresponds with SIRS 
while a low HLA-DR indicates CARS. The expression of HLA-DR may be used as an 
indicator for immunomodulation. In patients exhibiting a predominantly systemic 
inflammation, anti-inflammatory interventions may improve prognosis, while patients 
with sepsis and low HLA-DR expression may benefit from immunostimulation. 
Sepsis following orthotopic liver transplantation (OLT) is a complication that 
causes significant morbidity and mortality. Chapter 3 describes a prospective 
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observational study of 20 adult OLT patients. HLA-DR expression on monocytes was 
monitored during the first 4 weeks after transplantation. The seven patients who 
developed sepsis had a significantly lower HLA-DR expression on monocytes, both 
before and after they developed sepsis. In the two patients with sepsis who died, HLA-
DR expression remained low, while in the five septic patients who recovered, HLA-DR 
expression returned to normal values. The patients who developed sepsis had received 
significantly more prednisolone than the patients who did not. Incubation with 
prednisolone in vitro lowered the expression of HLA-DR in a dose-dependent manner. 
Low HLA-DR expression on monocytes appears to be a reliable risk marker for 
impending sepsis in OLT patients. The level of risk may be, at least in part, related to 
the dose of prednisolone. If HLA-DR is treated as a risk indicator for sepsis, treatment 
aimed at improving monocyte function or a reduction in steroids should be promptly 
initiated in those patients who show a low expression of HLA-DR to prevent the 
development of sepsis. 
 Laboratory values are routinely determined after the surgical repair of a 
ruptured abdominal aortic aneurysm (RAAA). In chapter 4 we present the results of a 
retrospective analysis of the course of all routinely determined laboratory values in 290 
RAAA patients. The purpose of the study was to describe the ‘normal or benign’ 
course of RAAA patients who survive until hospital discharge and to identify factors 
that distinguished them from the non-survivors. Both the survivors and the non-
survivors showed a wide range of laboratory abnormalities after surgery. The 
laboratory results were grouped into six categories (haematology and coagulation, 
systemic inflammation, metabolic, renal, liver, and electrolytes). The categories we 
chose are strongly related to the causes of death. For example, the patients who die of 
massive haemorrhage usually do so within the first 24 hours following surgery, 
whereas systemic inflammation and MOF develop more than 24 hours after surgery. 
We believe that recognition of the associated laboratory abnormalities is important as it 
may help in the early prediction and identification of post-operative complications. 
Chapter 5 describes systemic inflammation and HLA-DR expression on 
monocytes in RAAA patients in a prospective observational study. Thirty patients were 
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included and analysed consecutively. The primary outcome parameter was hospital 
mortality. Mortality was higher in older patients, patients with a higher APACHE-II 
(Acute Physiology and Chronic Health Inquiry) score, and the vital need for suprarenal 
clamping. The Sequential Organ Failure Assessment score (SOFA) was significantly 
higher in non-survivors from day 1 through day 14 after surgery. IL-6 and IL-10 were 
transiently higher on days 1 and 3 in non-survivors. HLA-DR expression on monocytes 
dropped after surgery in both survivors and non-survivors. However, in non-survivors 
HLA-DR expression was significantly lower from day 3 through day 14 after surgery 
compared with the survivors. Low HLA-DR expression was associated with multiple 
organ failure and death, although death from secondary infections was not seen in our 
patients. We conclude that shock and surgery lead to an overwhelming inflammatory 
response which sets the stage for fatal multiple organ failure. 
Rapid surgical intervention is one of the most important principles in the 
clinical management of patients with RAAA. Chapter 6 describes the importance of a 
multidisciplinary approach with clear protocols and dedication to the treatment of these 
patients. Our treatment protocol consisted of rapid transport by ambulance to the 
emergency department while accepting a low systolic blood pressure. During transport, 
the hospital was notified of imminent arrival of a patient with a possible RAAA. Only 
three of the 126 patients with ruptured abdominal aortic aneurysms were denied 
surgery. The average intrahospital delay was 25 minutes. Hospital mortality was 33%. 
Despite our liberal policy of offering surgery to almost every patient, hospital mortality 
was comparable to the best reported in the literature. 
The multicentre aneurysm screening study group has investigated the potential 
benefit of screening men aged 65-74 years for an abdominal aneurysm. In chapter 7, 
we emphasize that guidelines for the prompt treatment of ruptured aortic aneurysms 
should also be included when screening programs are implemented. Patients who 
develop a ruptured AAA despite the presence of a screening program should not be 
denied treatment due to an overly fatalistic view on their outcome. In our opinion, 
immediate surgery for RAAA patients is as cost effective as a screening program. 
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GENERAL DISCUSSION AND CONCLUSIONS 
 
Our results show that both OLT and RAAA patients develop an intense 
inflammatory response and depressed HLA-DR expression after surgery which is 
associated with high morbidity and mortality. Therefore, understanding the 
inflammatory response after major surgery is relevant and may provide opportunities to 
improve outcome in these patients. 
 
The implications for understanding the pathophysiology of SIRS 
The previously postulated SIRS/CARS sequence of events is depicted in the 
left panel of figure 1. A catastrophic event causes an inflammatory reaction that is 
followed by a counter-inflammatory response that theoretically should restore the 
balance of health. We also see these two phases in the OLT patients’ inflammatory 
response, but here they occur against the background of immunosuppression present as 












Figure 1. left panel the ‘normal’ pro- and anti-inflammatory response, illustrated by a 
mildly enhanced pro- and subsequently a counter-inflammatory response which re-
establishes equilibrium. The right panel shows the response in a patient with an 
overwhelming counter-inflammatory response which can be counteracted by early 
intervention (i.e. decreasing immunosuppressants). 
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In OLT patients, the intensity of the pro-inflammatory phase may be less 
intense as a result, and the counter-inflammatory phase becomes more pronounced than 
in other patients. This might explain the high incidence of sepsis related complications 
in our patient cohort. A timely reduction in immunosuppression (indicated by the arrow 
in the right panel of figure 1) might be effective in preventing these infections, as 
discussed below. 
To complicate matters, our observations in RAAA patients seriously challenge 
the SIRS/CARS concept of events. We did not see the development of any 
opportunistic infections which are the classical clinical manifestation of 
immunodeficiency. Instead, patients died from the complications of multiple organ 
failure which developed almost immediately after surgery. Additionally, our data (and 
those of others) show that the pro and counter inflammatory responses co-exist from 
the start (136,171,172). This is represented in figure 2.  
Whether these two types of inflammatory response contribute equally to the 
development of multiple organ failure is not clear. This warrants further research as it 











Figure 2.The co-existing pro- and anti-inflammatory response.  
 
Diagnostic and prognostic aspects of monocyte HLA-DR expression 
Previously, HLA-DR expression on monocytes was measured to predict septic 
complications after major surgery, trauma, severe burns, and for patients on a 
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ventricular assist device awaiting cardiac transplantation (23-27,62). Most studies 
showed that a persisting low HLA-DR expression was associated with poor outcome 
(79,136,142,173-176), however a few others could not confirm these results (177,178). 
These latter 2 studies measured HLA-DR expression on monocytes only during the 
first 2 post-operative days. Our studies on OLT and RAAA patients confirmed that 
HLA-DR expression on monocytes is an accurate predictor of outcome. Low HLA-DR 
expression on monocytes was present 1-8 days before the onset of clinical symptoms in 
all 7 patients who developed sepsis, and remained low in the 2 patients who died from 
sepsis. RAAA patients with a low HLA-DR expression on monocytes had a very poor 
prognosis. Non-survivors could be identified by a significantly lower intensity of HLA-
DR expression on monocytes as early as day 3, and preceding death by a median of 8 
days. 
The usefulness of monocyte HLA-DR expression, at least in RAAA patients, 
is somewhat limited by our finding that 3 days were required before a distinction 
between survivors and non-survivors could be made with any degree of statistical 
significance. This observation was confirmed by Monneret et al, who showed that 
HLA-DR expression on monocytes is significantly lower in the non-survivors after 3-4 
days (175). 
Laboratory markers such as lactate levels, platelet counts, CRP, pro-calcitonin, 
or cytokine levels also show marked differences between survivors and non-survivors. 
It remains to be determined which of these will serve as the most useful prognostic 
markers, and whether different markers will be required for different disease processes. 
 
Mechanism(s) of decreased HLA-DR expression 
It is not known which pathophysiological mechanism is responsible for the (low) HLA-
DR expression on monocytes; for example signal transduction or mRNA secretion 
might be important. A study by Fumeaux et al showed that IL-10 decreases HLA-DR 
expression. In patients with septic shock, this is probably due to re-endocytosis of 
HLA-DR and intracellular sequestration (179).  
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Our studies did not clarify whether low HLA-DR expression is “just” a 
clinically useful epiphenomenon or whether it constitutes a relevant element in the 
pathophysiologic chain that underlies SIRS. In the first theory, monocytes might be 
useful as surrogate markers in (immuno-)intervention studies (which by itself is 
important given the large numbers of patients required in randomised studies having 
survival as outcome parameter). In the second theory, monocytes (or their HLA-DR 
expression) might constitute a target for intervention. 
 
Therapeutic implications of monocyte HLA-DR expression 
Our observations in OLT patients strongly suggest that it is the combination of 
chronic illness, major surgery and immunosuppression that predisposes the patients to 
septic complications. While the first two of these factors cannot be changed, the 
intensity of immunosuppression can be easily adapted. The potential impact of such 
changes is illustrated by our observation that in vitro, prednisolone decreases HLA-DR 









Figure 3. The abrogated pro- and anti-inflammatory response by early intervention. 
 
Consequently, monitoring HLA-DR expression provides us with the 
opportunity to decrease immunosuppression pre-emptively in OLT patients at a high 
risk of developing sepsis in an effort to prevent this complication and improve 
outcome. Our findings justify undertaking a prospective, randomised study to 
determine whether the lowering of immunosuppression guided by low monocyte HLA-
DR expression decreases the incidence of septic complications. Indeed, our 
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observations on the effect of steroids on HLA-DR expression provides an argument for 
low-dose prednisolone or even steroid-free immunosuppression regimens that may be 
associated with a lower incidence of sepsis (180,181).  
 
The therapeutic consequences of low HLA-DR expression in other categories 
of patients such as those with RAAA are more difficult to envisage. As pro- and 
counterinflammatory responses co-exist, immuno-intervention should probably be 
aimed at lowering both these two responses. Intuitively it might be disadvantageous to 
“block” inflammation, thereby leaving counter-inflammation unopposed. Measures 
directed at both components of the response might be more beneficial (Figure 3).  
After Ronco et al. showed that a high ultrafiltration rate leads to a better 
prognosis in ICU patients with renal failure (182), the early initiation of renal 
replacement therapy in septic ICU patients became more accepted (183-186). Other 
investigators showed that high cutoff haemofiltration leads to lower levels of IL-6 and 
IL-1ra, which had a beneficial effect on leukocyte proliferation, polymorphonuclear 
function, and the amount of norepinephrine administered (187-189).  Furthermore, 
selective extracorporeal immunoabsorption lowers LPS, IL-6, and C5a levels, and 
leads to an increase in HLA-DR expression on monocytes. However, the effect on 
outcome in patients with sepsis has not yet been established (190).  
Hydrocortisone suppletion might also be beneficial, as a significant number of 
RAAA patients have relative adrenal insufficiency (153). Hydrocortisone restores 
haemodynamic stability and modulates the immune response and probably improves 
prognosis in patients with septic shock (151,152,191-193). One can speculate that this 
effect also holds for RAAA patients. In a subgroup of RAAA patients even high dose 
steroids might be beneficial. However, after the negative results of high dose steroids 
in patients with sepsis and the significant increase in secondary infections in the group 
of patients receiving methylprednisolone no more trials with high dose steroids were 
conducted (194). Nevertheless, hypothetically there may be a two group phenomenon. 
One group would have a relatively low pro- and anti-inflammatory response, and the 
second group would display a high inflammatory response. The first group would have 
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a good prognosis anyway, and would not benefit from the administration of 
methylprednisolone as they are less susceptible to multiple organ failure to begin with. 
The second group, which has the massive immune response may benefit from the 
administration of high dose steroids to mitigate that response. To our knowledge, these 
two groups have not been separately explored in the literature. It would be worthwhile 
to investigate a two group model, although more evidence supporting this theory would 
first be necessary before a study of high dose steroid treatment for patients with sepsis 
can be re-initiated. 
 
Prevention of RAAA  
In order to improve prognosis for RAAA patients, the benefits of screening for 
AAA need to be evaluated. The MASS study showed that screening elderly men for 
AAA reduced AAA-related mortality (54). However, it is unclear if screening remains 
beneficial when all the family members of an AAA patient are screened. Furthermore, 
the prevention of AAA related deaths may just change the cause of death in elderly 
patients without delaying it, i.e. a lower AAA related mortality may lead to more death 
from myocardial infarction and cancer (195). Meticulous surgical technique and 
increasing experience with endovascular repair for RAAA patients will likely also 
improve outcome. Hopefully this will be confirmed in a randomised controlled trial 
(196). In the meantime liberal and immediate surgery for RAAA patients is probably 
the best treatment for these patients (35).    
 
HLA-DR expression on monocytes is an important and relevant parameter in 
patients following liver transplantation and ruptured abdominal aortic aneurysm repair. 
Persistent low HLA-DR expression is associated with a high mortality in several 
patient groups. In this situation, OLT patients may benefit from a reduction in 
immunosuppressive medications, especially corticosteroids. In patients who have 
undergone RAAA repair, the low HLA-DR expression on monocytes is the result of an 
overwhelming pro- and anti-inflammatory response. These patients might benefit from 
hydrocortisone administration in the case of relative adrenal cortical insufficiency or 
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early high-volume venovenous haemofiltration. More knowledge on the intracellular 
mechanism responsible for modulating HLA-DR expression on monocytes is necessary 
to make individualised immunointervention treatment a success.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
110 
 
 
  
